Modern possibilities of using immunotherapy in the treatment of cervical cancer

Cervical cancer (CC) is the fourth most common cancer in women worldwide. Every year, more than 500,000 women are diagnosed with CC, and the disease leads to more than 300,000 deaths worldwide. Infection with the human papillomavirus is the cause of CC in most cases. The disease is largely preventab...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: A. V. Tarasova, K. A. Ganina, M. A. Meshkova, Yu. V. Solovyeva, E. E. Ivanova, L. N. Akimov
פורמט: Artigo
שפה:Russo
יצא לאור: ABV-press 2021-09-01
סדרה:Opuholi Ženskoj Reproduktivnoj Sistemy
נושאים:
immunotherapy
pembrolizumab
nivolumab
pd-1
pd-l1
biomarkers
גישה מקוונת:https://ojrs.abvpress.ru/ojrs/article/view/851
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים